Avadel Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-0.28	-48.83	-160.28	-137.46	-77.33	7.03
Depreciation & Amortization	3.68	2.68	1.77	1.49	0.82	1.69
Other Amortization	-	-	2.8	6.05	1.25	6.52
Loss (Gain) From Sale of Assets	-	-	-	-	-	-45.76
Asset Writedown & Restructuring Costs	20	-	-	-	-	-
Stock-Based Compensation	18.56	20.39	15.81	7.01	8.87	3
Other Operating Activities	-0.82	-0.83	14.39	28.07	-14.61	-6.89
Change in Accounts Receivable	-5.34	-21.99	-12.1	-	-	8.28
Change in Inventory	-8.01	-9.22	-9.53	-	-	-1.35
Change in Accounts Payable	4.49	-4.09	1.55	-3.11	4.23	-2.79
Change in Other Net Operating Assets	2.27	14.99	17.09	27.64	-0.54	-18.47
Operating Cash Flow	34.54	-46.91	-128.51	-70.3	-77.31	-48.73
Capital Expenditures	-0.19	-	-	-0.72	-0.03	-0.1
Divestitures	-	-	-	-	16.5	25.5
Sale (Purchase) of Intangibles	-15	-	-	-	-	-
Investment in Securities	25.73	51.78	-50.09	80.41	40.46	-95.12
Investing Cash Flow	10.54	51.78	-50.09	79.7	56.93	-69.72
Long-Term Debt Repaid	-	-	-38.67	-8.65	-	-
Net Debt Issued (Repaid)	-	-	-38.67	-8.65	-	-
Issuance of Common Stock	5.06	15.97	148.36	28	0.26	179.68
Other Financing Activities	-	-	25.64	-4.8	-	-
Financing Cash Flow	5.06	15.97	135.34	14.54	0.26	179.68
Foreign Exchange Rate Adjustments	1.09	-0.64	0.46	-0.66	-0.9	0.72
Net Cash Flow	51.23	20.2	-42.81	23.27	-21.01	61.95
Free Cash Flow	34.35	-46.91	-128.51	-71.02	-77.34	-48.83
Free Cash Flow Margin	13.82%	-27.74%	-459.57%	-	-	-218.64%
Free Cash Flow Per Share	0.35	-0.49	-1.60	-1.18	-1.32	-0.89
Cash Interest Paid	10.29	7.18	5.25	9.66	6.47	6.47
Cash Income Tax Paid	-	-	-	-29.06	0.08	-1.7
Levered Free Cash Flow	2.73	-30.37	-78.68	-25.39	-38.03	-57.42
Unlevered Free Cash Flow	8.8	-23.6	-75.3	-23.73	-33.07	-55.83
Change in Working Capital	-6.59	-20.32	-3	24.54	3.7	-14.32

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q